跳至主要内容
临床试验/NCT03719417
NCT03719417已完成不适用

A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Osteoarthritis (Expansion)

University of Missouri-Columbia2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2018年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
VAS Pain Score (Visual Analog Scale)

研究概览

简要总结

Participants will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of the knee using MOPSTM-preserved allografts (including menisci), anatomically-shaped allografts, autogenous bone marrow aspirate concentrate (BMC)-treated donor bone, and treatment-specific postoperative rehabilitation.

详细描述

With IRB approval, patients will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of the knee using MOPSTM-preserved allografts (including menisci), anatomically-shaped allografts, autogenous bone marrow aspirate concentrate (BMC)-treated donor bone, and treatment-specific postoperative rehabilitation. Demographic and operative data will be collected. Outcome assessments will include VAS pain, IKDC, SANE, Tegner and PROMIS Mobility for knee at 6 months and yearly after surgery. In addition, serial limb alignment measurements, ultrasonographic assessments of meniscal location and integrity, quantitative MRIs for cartilage composition, and serum and urine biomarkers for treatment monitoring will be performed. All complications and re-operations will be recorded. OCA survival will be determined based on maintenance of acceptable levels of pain and function and/or need for revision surgery or total knee arthroplasty.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Grade IV changes in the articular cartilage of the femoral condyle and tibial plateau and meniscal pathology in the medial or lateral femorotibial joint (unicompartmental) or unicompartmental and other femoral condyle, tibial plateau, trochlea and/or patella.
  • Between the age of 18-55

排除标准

  • Acute injury to any other part of the affected lower extremity
  • Inability to comply with protocol
  • BMI greater than 40
  • The subject is either pregnant or a prisoner
  • Currently involved in worker's compensation case at the time of enrollment

结局指标

主要结局

VAS Pain Score (Visual Analog Scale)

时间窗: 12 Months

This pain score is between 0 and 10, with 0 being no pain and 10 being the worst pain

次要结局

  • International Knee Documentation Committee Score (IKDC)(12 Months)
  • Single Assessment Numeric Evaluation (SANE) score(12 Months)
  • PROMIS Mobility(12 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James Stannard

Professor, Orthopedic Surgery

University of Missouri-Columbia

研究点 (2)

Loading locations...

相似试验

A Biologic Joint Replacement Strategy for Knee... | 临床试验